SUMMARY
Face recognition is important for both visual and social cognition. While congenital prosopagnosia (CP) or face blindness has been known for seven decades and electrophysiological studies have characterized face specific neurons for half a century, no molecular analyses have been undertaken. Here we report results of research combining classic genetics and modern genomics. From a large family with 18 CP members, we uncovered a fully co-segregating private mutation in the MCTP2 gene which encodes a calcium binding transmembrane protein expressed in the central nervous system. More rare mutations in MCTP2 were detected in CP families and were also associated with CPs in the cohort study. In another cohort of 1757, face recognition was different between 14 carriers with a frameshift mutation S80fs in MCTP2 and 19 non-carrying volunteers. 6 families including one with 10 members showed the S80fs-CP correlation. Functional magnetic resonance imaging (fMRI) indicates that impaired recognition of individual faces by CPs with the MCTP2 mutations is associated with inability to recognize the same faces in the right fusiform face area (rFFA). Our results have revealed the genetic predisposition of MCTP2 mutations in CP, 74 years after the initial report of CP. This is the first time a gene required for a higher form of visual social cognition was found in humans.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Our study of face recognition is more about cognitive genetics, not about a disease.
Funding Statement
The National Key Research and Development Program of China (2017YFE0126500) the National Natural Science Foundation of China (Project 32061143017) the National Natural Science Foundation of China (Project 31421003)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Committee for Protecting Human and Animal Subjects Department of Psychology Beijing University, China Tel & Fax: +86-10-6275 7551 Email: leiwang@pku.edu.cn
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Further information and requests for raw data, analysis details, and DNA samples may be directed to and fulfilled in compliance with IRB protocol requirements by Yi Rao (yrao@pku.edu.cn). Whole exome/genome sequencing data are not deposited in a public repository because the genetic sharing plans of the IRB approved consent forms used in this study do not permit the deposition of such data into public or controlled-access databases.
